[Functional gastrointestinal disorders (FGID): progress in diagnosis and treatments. Topic III. Recent topics; 1. Promising pharmacological therapy for FGID in the future].

[1]  K. Haruma,et al.  Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gastrointestinal symptoms: an omeprazole-controlled randomized study (J-FOCUS) , 2012, BMC Gastroenterology.

[2]  Y. Taché,et al.  Stress and visceral pain: From animal models to clinical therapies , 2012, Experimental Neurology.

[3]  M. Hongo,et al.  Large‐scale randomized clinical study on functional dyspepsia treatment with mosapride or teprenone: Japan Mosapride Mega‐Study (JMMS) , 2012, Journal of gastroenterology and hepatology.

[4]  Marcus J Claesson,et al.  An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota , 2011, Gut.

[5]  M. Hongo,et al.  A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia , 2011, Gut.

[6]  J. Tack,et al.  Acotiamide Hydrochloride (Z-338), a New Selective Acetylcholinesterase Inhibitor, Enhances Gastric Motility without Prolonging QT Interval in Dogs: Comparison with Cisapride, Itopride, and Mosapride , 2011, Journal of Pharmacology and Experimental Therapeutics.

[7]  W. Chey,et al.  Rifaximin therapy for patients with irritable bowel syndrome without constipation. , 2011, The New England journal of medicine.

[8]  M. Currie,et al.  Linaclotide improves abdominal pain and bowel habits in a phase IIb study of patients with irritable bowel syndrome with constipation. , 2010, Gastroenterology.

[9]  Yinglian Xiao,et al.  Prevalence and Symptom Pattern of Pathologic Esophageal Acid Reflux in Patients With Functional Dyspepsia Based on the Rome III Criteria , 2010, The American Journal of Gastroenterology.

[10]  K. Tominaga,et al.  Efficacy of the 5-HT1A Agonist Tandospirone Citrate in Improving Symptoms of Patients With Functional Dyspepsia: A Randomized Controlled Trial , 2009, The American Journal of Gastroenterology.

[11]  N. Talley,et al.  Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials , 2007, Gut.

[12]  N. Talley,et al.  Functional dyspepsia: A new Rome III paradigm , 2007, Current treatment options in gastroenterology.

[13]  F. Shanahan,et al.  Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. , 2005, Gastroenterology.

[14]  H. Imamura,et al.  Efficacy of Rikkunshito, a traditional Japanese medicine (Kampo), in treating functional dyspepsia. , 2010, Internal medicine.